Abstract: A synergistic plant fungicide is disclosed which comprises:(A) a morpholine compound selected from the group consisting of:(a) N-tridecyl-2,6-dimethylmorpholine;(b) N-cyclododecyl-2,6-dimethylmorpholine;(c) N-alkyl(C.sub.12)-2,6-dimethylmorpholine; and(d) 4-(3-p-tert.-butylphenyl)-2-methylpropyl-6-cis-dimethylmorpholine; or an agriculturally acceptable salt thereof; in combination with(B) a second compound selected from the group consisting of:(e) 2-chloro-N-(2,6-dimethylphenyl)-N-(tetrahydro-2- -oxo-3-furanyl)-acetamide;(f) 2-methoxy-N-(2-oxo-1,3-oxazolidin-3-yl)-N-(2,6-dimethylphenyl)-acetamide; wherein the weight ratio of Compound (A) to Compound (B) is 20:1 to 1:2.

Abstract: The invention relates to synergistic antifungal and plant-growth regulating compositions and to their application in plant-protection.The fungicides according to the invention contain the mixture of fungicide from the group of morpholines and acylalanines as active ingredients.

Abstract: Synergistic plant fungicides are disclosed which comprise Tridemorph and Benalaxyl in a synergistically effective weight ratio.

Abstract: Hydroxamic acids, pharmaceutical preparations containing the same, new .omega.(2'-naphthoxy)-alkylhydroxamic acids as well as a process for their production are disclosed. The new compounds display antiasthmatic and further pharmacologically valuable characteristics. They are prepared by reacting the corresponding carboxylic acid ester or amide with hydroxylamine or its salt under the described conditions into compounds of Formula I,R--CO--NH--OH.The compounds of Formula I are useful in human and veterinary medicine as medicaments the active principal of which is the inhibition of lipoxygenase, thus as antiasthmatic, antianaphylactic, antiphlogistic, antirheumatic and antithrombotic preparations.